AGGARWAL SUMIT (PRESIDENT AND CEO) exercised options at ELOXX PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/28/2025ACC: 0001104659-25-006784
DirectorOfficer· PRESIDENT AND CEO
Since Apr 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
30K acquired · 30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
17.7%
1/24/2025
169.93K→199.93K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/24/2025 | M · Option Exercise | +30K | — | — | 17.7% | 169.93K | 199.93K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
Held after
30K
Exercisable
—
1/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock30K shares | 1/24/2025 | M · Option Exercise | −30K | — | 30K |